clenbuterol has been researched along with Bone Loss, Osteoclastic in 1 studies
Clenbuterol: A substituted phenylaminoethanol that has beta-2 adrenomimetic properties at very low doses. It is used as a bronchodilator in asthma.
clenbuterol : A substituted aniline that is 2,6-dichloroaniline in which the hydrogen at position 4 has been replaced by a 2-(tert-butylamino)-1-hydroxyethyl group.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Clenbuterol treatment for several weeks prevented up to one-third of the reduction in mineralization of femurs and tibias caused by sectioning of the sciatic nerve in young rats." | 1.28 | Clenbuterol, a beta 2-receptor agonist, reduces net bone loss in denervated hindlimbs. ( Etlinger, JD; Guo, G; Hirschman, A; Hirschman, ML; Zeman, RJ, 1991) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Zeman, RJ | 1 |
| Hirschman, A | 1 |
| Hirschman, ML | 1 |
| Guo, G | 1 |
| Etlinger, JD | 1 |
1 other study available for clenbuterol and Bone Loss, Osteoclastic
| Article | Year |
|---|---|
Clenbuterol, a beta 2-receptor agonist, reduces net bone loss in denervated hindlimbs.
Topics: Adrenergic beta-Agonists; Animals; Bone and Bones; Bone Resorption; Clenbuterol; Denervation; Female | 1991 |